Organovo Holdings Inc. (ONVO)

1.84
NASDAQ : Health Technology
Prev Close 1.84
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.91 / 3.19
Avg Volume 966.70K
Exchange NASDAQ
Shares Outstanding 110.84M
Market Cap 195.07M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Organovo Holdings Stock Sees Short Interest Move 10.3% Lower

Organovo Holdings Stock Sees Short Interest Move 10.3% Lower

The most recent short interest data has been released for the 12/29/2017 settlement date, which shows a 1,746,022 share decrease in total short interest for Organovo Holdings Inc , to 15,136,112, a decrease of 10.34% since 12/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

Commit To Buy Organovo Holdings At $2, Earn 17.7% Annualized Using Options

Commit To Buy Organovo Holdings At $2, Earn 17.7% Annualized Using Options

Investors eyeing a purchase of Organovo Holdings Inc stock, but cautious about paying the going market price of $2.32/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2018 put at the $2 strike, which has a bid at the time of this writing of 15 cents.

These Biotech Stocks are BOOMING

These Biotech Stocks are BOOMING

Perrigo leading the charge.

Biotech Movers: Shire, Bellicum, Organovo

Biotech Movers: Shire, Bellicum, Organovo

Shire, Bellicum Pharmaceuticals and Organovo Holdings were among the biotech stock movers in premarket trading on June 22.

Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda

Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda

Intra-Cellular Therapies, Organovo Holdings and Acorda Therapeutics were among the biotech stock movers in premarket trading on Monday.

Biotech Movers: Organovo, Endo, Omeros

Biotech Movers: Organovo, Endo, Omeros

Organovo, Endo and Omeros were among the biotech stock moves in premarket trading on Thursday.

Biotech Movers: Neurocrine Biosciences Leaps on Drug Approval, Synergy Pharma Issued Three Patents

Biotech Movers: Neurocrine Biosciences Leaps on Drug Approval, Synergy Pharma Issued Three Patents

The company's shares were up 24% ahead of market's open on an FDA approval.

Organovo Announces CEO Transition

TheStreet Quant Rating: D- (Sell)